Vadim S. Koshkin MD
Assistant Professor, University of California, San Francisco, CaliforniaVadim Koshkin is a genitourinary medical oncologist at the University of California San Francisco with interests in clinical and translational research. He completed his medical school at the University of Chicago Pritzker School of Medicine, internal medicine training at the University of Michigan and oncology fellowship at the Cleveland Clinic. He started as faculty at the University of California San Francisco (UCSF) in 2018, focusing on the care of patients with genitourinary malignancies and on building the bladder cancer program. His research interests have focused on clinical trials, targeted agents and biomarkers in bladder cancer, as well as radioligand therapies and imaging in bladder and prostate cancer. He is co-leading the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study, a large, multi-institutional, retrospective study of patients with advanced urothelial cancer treated with novel ADCs and targeted agents. At UCSF he serves as the site committee co-chair of the Molecular Imaging & Radionuclide Therapy site committee. Dr. Koshkin is the author of numerous manuscripts and book chapters including first author publications in JCO, Clinical Cancer Research, Cancer and JITC, and has presented his research at numerous national meetings.
Disclosures
Dr. Koshkin has served in a consulting or advisory role for AstraZeneca, Clovis, Janssen, Pfizer, EMD Serono, Seagen, Astellas, Dendreon, Guidepoint, GLG and ExpertConnect; has received research funding for the institution from Endocyte, Nektar, Clovis, Janssen and Taiho and is supported by the Prostate Cancer Foundation.